These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29110282)

  • 1. Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist.
    Kotańska M; Kulig K; Marcinkowska M; Bednarski M; Malawska K; Zaręba P
    J Endocrinol Invest; 2018 May; 41(5):609-619. PubMed ID: 29110282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrrolidin-2-one derivatives may reduce body weight in rats with diet-induced obesity.
    Dudek M; Knutelska J; Bednarski M; Nowiński L; Zygmunt M; Kazek G; Mordyl B; Głuch-Lutwin M; Zaręba P; Kulig K; Sapa J
    Eur J Pharmacol; 2016 Apr; 776():146-55. PubMed ID: 26896778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
    Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as α
    Rak A; Canale V; Marciniec K; Żmudzki P; Kotańska M; Knutelska J; Siwek A; Stachowicz G; Bednarski M; Nowiński L; Zygmunt M; Zajdel P; Sapa J
    Bioorg Med Chem; 2016 Nov; 24(21):5582-5591. PubMed ID: 27658792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Raźny K; Sapa J; Malawska B; Kulig K
    Bioorg Med Chem; 2015 May; 23(9):2104-11. PubMed ID: 25813897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity.
    Dudek M; Knutelska J; Bednarski M; Nowiński L; Zygmunt M; Mordyl B; Głuch-Lutwin M; Kazek G; Sapa J; Pytka K
    PLoS One; 2015; 10(10):e0141327. PubMed ID: 26506439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible mechanism of hypotensive activity of some pyrrolidin-2-one derivatives with antagonist properties at alpha1-adrenoceptors.
    Sapa J; Kubacka M
    Eur J Pharmacol; 2011 Dec; 673(1-3):40-8. PubMed ID: 21605554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of non-quinazoline α
    Kubacka M; Kotańska M; Szafarz M; Pociecha K; Waszkielewicz AM; Marona H; Filipek B; Mogilski S
    Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):751-760. PubMed ID: 31133498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
    Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
    Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists.
    Hayashi R; Ohmori E; Moriwaki M; Kumagai H; Isogaya M
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3921-3. PubMed ID: 26238322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
    Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine.
    Kubacka M; Mogilski S; Filipek B; Marona H
    Eur J Pharmacol; 2013 Jan; 698(1-3):335-44. PubMed ID: 23117089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities.
    Handzlik J; Bajda M; Zygmunt M; Maciąg D; Dybała M; Bednarski M; Filipek B; Malawska B; Kieć-Kononowicz K
    Bioorg Med Chem; 2012 Apr; 20(7):2290-303. PubMed ID: 22381672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2013 Sep; 715(1-3):262-9. PubMed ID: 23707349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, alpha-adrenoceptors affinity and alpha 1-adrenoceptor antagonistic properties of some 1,4-substituted piperazine derivatives.
    Marona H; Kubacka M; Filipek B; Siwek A; Dybała M; Szneler E; Pociecha T; Gunia A; Waszkielewicz AM
    Pharmazie; 2011 Oct; 66(10):733-9. PubMed ID: 22026152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and β-adrenoceptor antagonist.
    Kubacka M; Mogilski S; Bednarski M; Raźny K; Sapa J; Waszkielewicz AM; Marona H; Filipek B
    Pharmacology; 2014; 94(5-6):287-95. PubMed ID: 25531925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
    McDaid J; Docherty JR
    Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists.
    Abou-Seri SM; Abouzid K; Abou El Ella DA
    Eur J Med Chem; 2011 Feb; 46(2):647-58. PubMed ID: 21193252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on novel pyridine and 2-pyridone derivatives of N-arylpiperazine as α-adrenoceptor ligands.
    Baran M; Kepczyńska E; Zylewski M; Siwek A; Bednarski M; Cegła MT
    Med Chem; 2014 Mar; 10(2):144-53. PubMed ID: 23627274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
    Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
    Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.